Pharmacological rationale for the management of PMS

References

• Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 1931; 26: 1053
   Google Scholar
• Dalton K. The premenstrual syndrome. Heinemann, London 1964
   Google Scholar
• Dalton K. The premenstrual syndrome and progesterone therapy. Heinemann, London 1977
   Google Scholar
• Bäckström T, Carstensen H. Estrogen and progesterone in plasma in relation to menstrual tension. J Steroid Biochem 1974; 5: 257
   PubMedGoogle Scholar
• Munday MR. Hormone levels in severe premenstrual tension. Curr Med Res Opin 1977; 4: 16, Suppl 4
   Web of Science ®Google Scholar
• Munday M R, Brush M G, Taylor RW. Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clin Endocr 1981; 14: 1
   PubMed Web of Science ®Google Scholar
• Munday MR. Endocrine studies in the premenstrual syndrome. Ph D thesis, University of London. 1979
   Google Scholar
• Brush MG. Endocrine and other biochemical factors in the aetiology of the premenstrual syndrome. Curr Med Res Opin 1979; 6, Supper 19
   Web of Science ®Google Scholar
• Sampson G. The rational use of progestagens. MIMS Magazine 1st April, 1982; 14
   Google Scholar
• Landau R L, Lugibihl K. The catabolic and naturiuretic effects of progesterone in man. Rec Progr Harm Res 1961; 17: 249
   PubMedGoogle Scholar
• Oelkers W, Marsen B, Molzahn M, Lohmann F W, Hammerstein J. Relationship between weight changes and renin, aldosterone, estrogens and progesterone in cyclical oedema. Acta Endocr 1973; 159, Suppl 173
   Google Scholar
• Herrmann W M, Beach RC. Experimental and clinical data indicating the psychotropic properties of progestogens. Postgrad Med J 1978; 54: 82, Suppl 2
   PubMed Web of Science ®Google Scholar
• Taylor RW. The treatment of premenstrual tension with dydrogesterone ('Duphaston'). Curr Med Res Opin 1977; 4: 35, Suppl 4
   Web of Science ®Google Scholar
• Kerr G D, Day J B, Munday M R, Brush M G, Watson M, Taylor RW. Dydrogesterone in the treatment of the premenstrual syndrome. Practitioner 1980; 224: 852
   PubMedGoogle Scholar
• Haspels AA. A double-blind, placebo controlled multicentre study of the efficacy of dydrogesterone ('Duphaston'). The premenstrual syndrome, Pa. van Keep, Wh. Utian. MTP Press, Lancaster 1981; 81–92
   Google Scholar
• Sampson G. Premenstrual syndrome. A double-blind controlled trial of progesterone and placebo. Br J Psychiat 1979; 135: 209
   PubMed Web of Science ®Google Scholar
• Baumblatt M J, Winston F. Pyriodoxine and the pill. Lancett 1970; 1: 832
   PubMed Web of Science ®Google Scholar
• Adams P W, Rose D P, Folkardj, Wynn V, Seed M, Strong R. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1973; 1: 897
   Web of Science ®Google Scholar
• Winston F. Oral contraceptives, pyridoxine and depression. Am J Psychiatr 1973; 130: 1217
   PubMed Web of Science ®Google Scholar
• Kerr GD. The management of the premenstrual syndrome. Curr Med Res Opin 1977; 4: 29, Suppl 4
   Web of Science ®Google Scholar
• Day J B, Brush M G, Munday M R, Wheeler M J, Watson M. A placebo controlled trial and endocrine study on the treatment of premenstrual syndrome with a long-acting preparation of pyridoxine (Comploment). 1983, To be submitted for publication
   Google Scholar
• Brush MG. Premenstrual syndrome: aetiology and treatment. Pulse 1982; 42: 62
   Google Scholar
• Brush MG. The possible mechanisms causing the premenstrual tension syndrome. Curr Med Res Opin 1977; 4: 9, Suppl 4
   Web of Science ®Google Scholar
• Brush MG. The pill, pyridoxine and PMS symptoms. MIMS Magazine 1st Apr, 1982b; 18
   Google Scholar
• Brenner RR. The oxidative desaturation of unsaturated fatty acids in animals. Molec Cell Biochem 1974; 3: 41
   PubMed Web of Science ®Google Scholar
• Brush MG. Efamol(gamma-linolenic acid) in the treatment of the premenstrual syndrome. Clinical uses of essential fatty acids, DF. Horrobin. Raven, New York 1983, in press
   Google Scholar
• Horrobin DF. Prolactin: Physiology and clinical significance. MTP Press, Lancaster 1973; 115–120
   Google Scholar
• Andersen A N, Larsen J F, Steenstrup O R, Svendstrup B, Nielsen J. Effect of bromocryptine on the premenstrual syndrome. A double-blind clinical trial. Br J Obstet Gynaecol 1977; 84: 370
   PubMedGoogle Scholar
• Andersch B, Hahn L, Wendestam C, Ohman R, Abrahamsson L. Treatment of premenstrual tension syndrome with bromocryptine. Acta Endocr 1978; 88: 165, Suppl 216
   Google Scholar
• Bäckström T, Aakvaag A. Plasma prolactin and testosterone during the luteal phase in women with premenstrual tension syndrome. Psychoneuroendocr 1981; 6: 245
   PubMed Web of Science ®Google Scholar
• Harrison P, Letchworth AT. Bromocriptine in the treatment of the premenstrual syndrome. Proc Symp held at Royal College of Physicians (14th May 1976) London 1976; 103
   Google Scholar
• Ghosh K, Coppen A. Bromocriptine and premenstrual syndrome: controlled study. Br Med J 1977; 1: 147
   Google Scholar
• Elsner C W, Buster K E, Schindler R A, Nessim S A, Abraham GE. Bromocriptine in the treatment of premenstrual tension syndrome. Obstet Gynecol NY 1980; 56: 723
   PubMed Web of Science ®Google Scholar
• Martin-Comin J, Pujol-Amat P, Cararach V, Davi E, Robyn C. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-brom-alpha-ergocryptine (CB-154). Obstet Gynecol 1977; 48: 703
   Web of Science ®Google Scholar
• Palmer V B, Jcmp Monteiro. Bromocriptine for severe mastalgia. Br Med J 1977; 1: 1083
   PubMedGoogle Scholar
• Blichert-Toft M, Andersen A N, Henriksen O B, Mygind T. Treatment of mastalgia with bromocriptine: double-blind cross-over study. Br Med J 1979; 1: 237
   PubMedGoogle Scholar
• Mansel R E, Preece P E, Hughes LE. A double-blind trial of the prolactin inhibitor bromocryptine in painful benign breast disease. Br J Surg 1978; 65: 724
   PubMed Web of Science ®Google Scholar
• O'brien PMS, Craven D, Selby C, Symonds EM. Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 1979; 86: 142
   PubMedGoogle Scholar
• O'brien Pms. Value of tranquillizers and diuretics in PMS. MIMS Magazine 1st Apr, 1982; 10
   Google Scholar